After the FDA warning and removal of rosiglitazone from the VA National Formulary, glucose control may have declined among those discontinuing rosiglitazone without receiving replacement medication.
Roslyn A. Stone, PhD
Advertisement
Articles by Roslyn A. Stone, PhD
Advertisement
Latest Updated Articles
- FDA Warning and Removal of Rosiglitazone From VA National Formulary
September 19th 2013
Advertisement
Advertisement
Trending on AJMC
1
Patient Portal Messages Outpace Office Visits
2
Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors
3
Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly
4
Social Factors May Match, Outpace Genetic Risk in Disease Prediction
5